Depression in Patients with Heart Failure: Clinical Implications and Management

Abstract

Mortality and morbidity rates remain high in patients with heart failure despite advances in medical therapy. Heart failure can also significantly worsen quality of life. Attention has been paid to evaluating the effects of psychological disease in patients with heart failure. Depression rates are higher in patients with heart failure than in the general population. Depression has been associated with worse outcomes in patients with heart failure. Those at highest risk for depression include patients with implantable cardioverter-defibrillators, alcohol abuse, history of depression, and multiple comorbidities. Depression may be underdiagnosed in the heart failure population, as symptoms can often be similar in the two disease states. Evidence is limited on the effects of pharmacologic and nonpharmacologic therapy for depression, specifically in patients with heart failure. Based on the available literature, patients with heart failure should be screened routinely for depression. Treatment is known to improve quality of life, but its effect on outcomes such as mortality and hospital admissions for heart failure remains unknown. If treatment includes pharmacologic strategies, selective serotonin reuptake inhibitors (especially paroxetine and sertraline), mirtazapine, and nefazodone have the strongest efficacy evidence in this population. Based on safety data of these agents and after consideration of comorbid conditions and the potential for drug interactions, a selective serotonin reuptake inhibitor should be used as first-line therapy. Finally, clinicians should not avoid beta-blockers in those with a diagnosis of depression, as recent evidence demonstrates that these agents are not associated with inducing or worsening depressive symptoms.

The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan

“…Additionally, the results of the present study showed a positive association between depression and migraine and heart condition comorbidities. Several studies reported the relationship of depression with cardiovascular disease [27,28], which is well known to be correlated with RA [29,30].…”

Depression After Myocardial Infarction

“…The primary mechanism of action of SSRIs results in increased serotonin circulation by blocking presynaptic serotonin receptors. This results in a downregulation of the actual receptors, sustaining the level of circulating serotonin [30,32]. This effect has been shown to improve mood in patients with depression, decreasing the prevalence of clinical depression.…”

Depressed or Not Depressed: Untangling Symptoms of Depression in Patients Hospitalized With Coronary Heart Disease

“…possibly, either patients with ACs or patients without the syndrome had greater experience with cardiac symptoms, a situation that could have influenced the different rates of depression in the 2 groups, because chronic heart disease is associated with greater rates of depression than is newonset disease. 33 We did not assess the occurrence of previous cardiac events or the duration of CHD in our sample. Thus, we cannot examine the influence of living with CHD on rates of depression in our patients.…”